COMPASS THERAPEUTICS INC (CMPX) Stock Earnings Estimates
NASDAQ:CMPX • US20454B1044
6 USD
+0.11 (+1.87%)
At close: Feb 24, 2026
6.04 USD
+0.04 (+0.67%)
After Hours: 2/24/2026, 8:17:54 PM
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 850K | -100.00% | 7.734M | 71.995M 830.89% | 220.07M 205.67% | 378.06M 71.79% | 590.06M 56.08% | 1.049B 77.78% | 1.539B 46.71% | 2.118B 37.62% | |||
| EBITDA YoY % growth | -40.88M 49.72% | -49.664M -21.49% | -56.036M -12.83% | -78.576M -40.22% | -90.392M -15.04% | -74.511M 17.57% | -16.463M 77.91% | 28.325M 272.05% | 123.95M 337.60% | 167.63M 35.24% | 211.1M 25.93% | 226.52M 7.30% | |
| EBIT YoY % growth | -41.66M 49.12% | -50.363M -20.89% | -56.625M -12.43% | -75.114M -32.65% | -84.25M -12.16% | -94.532M -12.20% | 11.18M 111.83% | 139.13M 1,144.45% | 307.47M 120.99% | 775.9M 152.35% | 1.207B 55.56% | 1.709B 41.59% | |
| Operating Margin | N/A | N/A | -6,661.76% | N/A | -1,089.35% | -131.30% | 5.08% | 36.80% | 52.11% | 73.97% | 78.43% | 80.69% | |
| EPS YoY % growth | -0.37 69.70% | -0.34 8.11% | -0.37 -8.82% | -0.44 -19.15% | -0.46 -3.31% | -0.50 -10.26% | 0.08 115.23% | 0.58 658.67% | 1.32 127.10% | 3.16 139.57% | 4.40 39.32% | 5.87 33.51% |
All data in USD
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | Q1 / 28 | Q2 / 28 | Q3 / 28 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.10 12.47% | -0.11 7.26% | -0.11 19.29% | -0.11 -38.83% | -0.11 -18.11% | -0.07 34.47% | -0.06 45.84% | -0.03 74.29% | -0.03 74.44% | 0.02 132.17% | 0.04 165.00% | 0.04 232.14% |
| Revenue Q2Q % growth | 2.38M | 6.477M | 3.06M | 10.2M 328.57% | 20.563M 217.48% | N/A | N/A | N/A | ||||
| EBITDA Q2Q % growth | -22.787M -42.55% | -19.156M -10.15% | -19.768M 2.79% | -20.451M -38.98% | -20.839M 8.55% | -21.247M -10.92% | -19.176M 2.99% | -13.841M 32.32% | -5.947M 71.46% | N/A | N/A | N/A |
| EBIT Q2Q % growth | -17.243M -4.04% | -19.234M -15.80% | -20.08M 4.68% | -21.047M -33.07% | -23.786M -37.94% | -21.257M -10.52% | -19.186M 4.45% | -13.852M 34.19% | -5.957M 74.96% | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | -0.08 | -0.14 | 0.06 | 42.98% |
| Q2 2025 Q2Q % growth | -0.14 -40.00% | -0.12 | -0.02 | -12.30% |
| Q1 2025 Q2Q % growth | -0.12 -50.00% | -0.11 | -0.01 | -5.99% |
| Q4 2024 Q2Q % growth | -0.11 | -0.10 | -0.01 | -9.93% |
| Q3 2024 Q2Q % growth | -0.08 | -0.12 | 0.04 | 30.79% |
| Q2 2024 Q2Q % growth | -0.10 -11.11% | -0.10 | 0.00 | -3.20% |
| Q1 2024 Q2Q % growth | -0.08 -33.33% | -0.12 | 0.04 | 30.51% |
| Q4 2023 Q2Q % growth | -0.11 -10.00% | -0.10 | -0.01 | -14.56% |
| Q3 2023 Q2Q % growth | -0.08 33.33% | -0.11 | 0.03 | 26.80% |
| Q2 2023 Q2Q % growth | -0.09 -12.50% | -0.08 | -0.01 | -8.36% |
| Q1 2023 Q2Q % growth | -0.06 14.29% | -0.11 | 0.05 | 45.82% |
| Q4 2022 Q2Q % growth | -0.10 52.38% | -0.11 | 0.01 | 12.85% |
| Q3 2022 Q2Q % growth | -0.12 -20.00% | -0.11 | -0.01 | -10.29% |
| Q2 2022 Q2Q % growth | -0.08 | -0.09 | 0.01 | 6.95% |
| Q1 2022 Q2Q % growth | -0.07 | -0.11 | 0.04 | 37.61% |
| Q4 2021 Q2Q % growth | -0.21 | -0.07 | -0.14 | -182.57% |
| Q3 2021 Q2Q % growth | -0.10 | -0.13 | 0.03 | 21.57% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -100.00% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 4.07% | 15.58% | 0.92% | 20.06% |
| Revenue | N/A | N/A | N/A | N/A |